Skip to main content

The news desk

AI news, checked against the source.

What changed in AI, one story at a time. Each one links to its primary source, and facts stay apart from interpretation.

Last updated ·

Wednesday, November 18UTC

  1. New
    BoltzBiomolecular AI financingFunding & Deals

    Boltz announces $110 million Series A for molecular design AI

    Boltz announced a $110 million Series A led by Bessemer Venture Partners to invest in compute, data and its molecular design tools. The company says six top-20 pharma companies are partners and reports growth in usage; those operating claims come from Boltz and are not proof of drug-development outcomes.

    Boltz2 sources

Free, email only

Unlock the full brief free.

  • Thirty days of stories to browse, not seven
  • On every story: what to check, each source and why it matters
  • The same signup unlocks every free tool

Continuing subscribes the email on that account to Work Worth Doing, my newsletter, the same as the form below, and unlocks every free tool in this browser. We only receive your email address. Unsubscribe in one click.

This is not an account: there is no password, and the unlock is a cookie in this browser. You also join Work Worth Doing, Demetri Panici's newsletter, every week: what I built and what changed in AI. We'll email you a link to confirm, and you can unsubscribe in one click. The same signup unlocks every free tool on the site. How your email is handled.

Already subscribed? Enter the same email to unlock this browser. You won't be signed up twice.

Days are UTC. Some sources report an exact time and others only a date; both are placed on their UTC day.